Chargement en cours...
Review of PD-1/PD-L1 Inhibitors in Metastatic dMMR/MSI-H Colorectal Cancer
There are a wide range of therapies for metastatic colorectal cancer (CRC) available, but outcomes remain suboptimal. Learning the role of the immune system in cancer development and progression led to advances in the treatment over the last decade. While the field is rapidly evolving, PD-1, and PD-...
Enregistré dans:
| Publié dans: | Front Oncol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6527887/ https://ncbi.nlm.nih.gov/pubmed/31139574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00396 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|